Information Provided By:
Fly News Breaks for March 4, 2019
EVH
Mar 4, 2019 | 08:10 EDT
KeyBanc analyst Donald Hooker lowered his price target for Evolent Health to $20 from $32, while reiterating an Overweight rating on the shares after its largest client, Passport Health Plan, announced cost cuts that should save it from imminent insolvency. The cost reductions appear to include a cut in fees to Evolent Health and lowered reimbursement to its provider network, he notes.